C4 Therapeutics Inc. (CCCC)
1.42
-0.10 (-6.58%)
At close: Apr 03, 2025, 1:11 PM
C4 Therapeutics Analyst Ratings
Total Analysts
4
Consensus Rating
Buy
Price Target
13
Upside
815.49
Ratings History
| Analyst | Firm | Rating | Action | Price Target | Upside | Date |
| Wells Fargo | Buy | Upgrades | 8 12 | 745.07% | Dec 19, 2024 | |
| Stephens & Co. | Hold | Initiates | 4 | 181.69% | Nov 18, 2024 | |
| BMO Capital | Buy | Initiates | 20 20 | 1308.45% | Aug 6, 2024 |
Trade Smarter, Not Harder
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.